Post operative Pain Management -A comparative study of two different doses of Dexmedetomedine as an adjuvant to Bupivacaine in epidural infusion.
- Conditions
- Health Condition 1: 4- Measurement and Monitoring
- Registration Number
- CTRI/2023/06/053538
- Lead Sponsor
- ACS MEDICAL COLLEGE AND HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
ALL PATIENTS WILLING FOR STUDY.
PATIENTS WITH BOTH GENDERS
PATIENTS WHO ARE CONSIOUS AND ORIENTED
ALL PATIENTS UNDERGOING SURGERIES BELOW LEVEL OF UMBILICUS
ALL PATIENTS UNDER ASA 1, ASA 2, ASA 3 CATEGORIES,
ALL PATIENTS UNDERGOING SURGERIES WITH SOLO EPIDURAL PROCEDURE, EPIDURAL WITH SPINAL WITH SPINAL DRUG WITH NO ADJUVANTS ,
PATIENTS WHO REFUSE FOR PROSEDURE
PREGNANT PATIENTS
PATIENTS WITH SPINAL BIRTH DEFECTS,HEMATOLOGICAL CONDITIONS ,HEMOSTATIC DISORDERS
OBESE PATIENTS
PATIENTS WITH CHRONIC BACK PAIN
PSYCHIATRIC PATIENTS
UNCONSIOUS,NOT ORIENTED,COMATOSED PATIENTS.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) HAEMODYNAMIC AND RESPIRATORY PARAMETERS ( BP,PULSE,SPO2,MAP) <br/ ><br> <br/ ><br>2) VISUAL ANALOGUE PAIN SCORE MONITORING DURING PROCEDURE <br/ ><br>(VAS SCORE 1 TO 10)Timepoint: 1.at beginning of epidural infusion <br/ ><br>2.at 5 min after first dose <br/ ><br>3.at 10 min after beginning infusion <br/ ><br>4.at 20 min after beginning of infusion <br/ ><br>5.at 1hr after beginning of infusion <br/ ><br>6.at 6hrs after beginning of infusion <br/ ><br>7.at 12 hrs after beginning of infusion <br/ ><br>8.at 24hrs after beginning of infusion
- Secondary Outcome Measures
Name Time Method 1) DOSE OF DRUG AT WHICH PATIENT GETS MAXIMUM PAIN RELIEF.Timepoint: DURING THE PROCEDURE